Preclinical testing of a new combinatorial therapy against Aurora A and G9a for the treatment of pancreatic cancer

Preclinical testing of a new combinatorial therapy against Aurora A and G9a for the treatment of pancreatic cancer

G Lomberk, R Urrutia - Pancreatology, 2013 - pancreatology.net

... of pancreatic carcinoma Zhigong Zhang 1, H. Habisch 2, S. Zhou 2, M. Siech 3, X. Geng 1, M.
Bachem 2, Max Bachem 2 1 ... We plan to report valuable data that may constitute a basis for clinical
application of regimens that include tumor-penetrating cyclic peptide (iRGD), which ...

Peptide synthesis, peptide modification and peptide library synthesis, please contact:

Eva He

eva@pepmic.com

Pepmic Co., Ltd

www.pepmic.com